Osteoclast-associated receptor blockade prevents articular cartilage destruction via chondrocyte apoptosis regulation

Osteoarthritis (OA), primarily characterized by articular cartilage destruction, is the most common form of age-related degenerative whole-joint disease. No disease-modifying treatments for OA are currently available. Although OA is primarily characterized by cartilage destruction, our understanding of the processes controlling OA progression is poor. Here, we report the association of OA with increased levels of osteoclast-associated receptor (OSCAR), an immunoglobulin-like collagen-recognition receptor. In mice, OSCAR deletion abrogates OA manifestations, such as articular cartilage destruction, subchondral bone sclerosis, and hyaline cartilage loss. These effects are a result of decreased chondrocyte apoptosis, which is caused by the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in induced OA. Treatments with human OSCAR-Fc fusion protein attenuates OA pathogenesis caused by experimental OA. Thus, this work highlights the function of OSCAR as a catabolic regulator of OA pathogenesis, indicating that OSCAR blockade is a potential therapy for OA.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Nature communications - 11(2020), 1 vom: 28. Aug., Seite 4343

Sprache:

Englisch

Beteiligte Personen:

Park, Doo Ri [VerfasserIn]
Kim, Jihee [VerfasserIn]
Kim, Gyeong Min [VerfasserIn]
Lee, Haeseung [VerfasserIn]
Kim, Minhee [VerfasserIn]
Hwang, Donghyun [VerfasserIn]
Lee, Hana [VerfasserIn]
Kim, Han-Sung [VerfasserIn]
Kim, Wankyu [VerfasserIn]
Park, Min Chan [VerfasserIn]
Shim, Hyunbo [VerfasserIn]
Lee, Soo Young [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
OSCAR protein, human
Oscar protein, mouse
Receptors, Cell Surface
Research Support, Non-U.S. Gov't
TNF-Related Apoptosis-Inducing Ligand
Tnfsf10 protein, mouse

Anmerkungen:

Date Completed 17.09.2020

Date Revised 28.08.2021

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41467-020-18208-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM314331018